It is a financial services enterprise based in New Delhi, Delhi, India, established in 2019.
2019 | New Delhi, Delhi, India | ActiveGecare Pharmaceuticals (Opc) Private Limited, Engaging in diversified financial services within the financial services sector, it holds CIN: U24290DL2019OPC351206. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Saroj Garg (Director), Sangita Goel (Director), Santosh Jindal (Director). Past directors included Potru Hanumantha Rao, Saroj Garg, Sangita Goel. Its latest balance sheet filed on 31 March 2025. It is based at 272, 3Rd Floor, Rajdhani Enclave Pitampura, Landmark Near Rani Bagh, New Delhi, Delhi, 110034.
U24290DL2019OPC351206
351206
11 June 2019
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Gecare Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saroj Garg | Director | 15 Dec 2020 | Current |
| Sangita Goel | Director | 15 Dec 2020 | Current |
| Santosh Jindal | Director | 15 Dec 2020 | Current |
| Renu Sukhija | Director | 15 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gecare Pharmaceuticals (Opc) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.74% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Gecare Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gecare Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gecare Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gecare Pharmaceuticals (Opc)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gecare Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
The activity Saroj Garg was appointed as a Director was appointed as a Director on 15 Dec 2020 & has been associated with this company since 5 years 1 day . was completed.
Sangita Goel was appointed as a Director was appointed as a Director on 15 Dec 2020 & has been associated with this company since 5 years 1 day . was recorded as a recent event.
Progress on Santosh Jindal was appointed as a Director was appointed as a Director on 15 Dec 2020 & has been associated with this company since 5 years 1 day . was documented.
The activity Renu Sukhija was appointed as a Director was appointed as a Director on 15 Dec 2020 & has been associated with this company since 5 years 1 day . was completed.
The activity Gecare Pharmaceuticals (Opc) Private Limited was registered on 11 Jun 2019 with Roc Delhi & aged 6 years 6 months as per MCA records. was completed.
The CIN of Gecare Pharmaceuticals (Opc) Private Limited is U24290DL2019OPC351206.
Gecare Pharmaceuticals (Opc) Private Limited is headquartered at 272, 3Rd Floor, Rajdhani Enclave Pitampura, Landmark Near Rani Bagh, New Delhi, Delhi, 110034.
Gecare Pharmaceuticals (Opc) Private Limited was incorporated on 11 June 2019.
The current directors of Gecare Pharmaceuticals (Opc) Private Limited are
The primary industry of Gecare Pharmaceuticals (Opc) Private Limited is Financial Services.
Gecare Pharmaceuticals (Opc) Private Limited is unlisted.
The authorized capital of Gecare Pharmaceuticals (Opc) Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX